Clinical value of procalcitonin in critically ill patients infected by SARS-CoV-2 - 29/07/21
, Conxita Rovira a, Elisabet Garcia a, Ana Parra a, Raquel Enriquez a, Armando Pinos a, Manuel Sosa a, Anna Hernández-Aguilera b, Immaculada Vallverdú a
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Abstract |
Background Blood procalcitonin (PCT) levels usually increase during infectious diseases and might be helpful to differentiate bacterial from non-bacterial origin. COVID-19 patients could present co-infections at initial presentation in the Emergency Department and nosocomial infections during stay in the ICU. However, the published literature has not established whether PCT changes could aid in the diagnosis of infectious complication during the COVID-19 pandemic. Methods Retrospective, single-center, cohort study, including COVID-19 patients admitted between March and May 2020. The data were prospectively collected for department purposes; laboratory results were collected automatically at admission and during the whole patient admission. Results 56 patients were analyzed (female 32%, male 68%), 35 were admitted to ICU, and 21 received general ward care. 21 ICU patients underwent mechanical ventilation (88%), and 9 died during admission (26%). Non-survivors had higher initial blood PCT levels than survivors at ICU admission (p.
Le texte complet de cet article est disponible en PDF.Plan
Vol 46
P. 525-531 - août 2021 Retour au numéro
Article précédent
- Association between COVID-19 diagnosis and presenting chief complaint from New York City triage data
- Christopher T. Clifford, Trevor R. Pour, Robert Freeman, David L. Reich, Benjamin S. Glicksberg, Matthew A. Levin, Eyal Klang
- Racial and ethnic disparities in hospital observation in Maryland
- Cody Cichowitz, Gideon Loevinsohn, Eili Y Klein, Elizabeth Colantuoni, Panagis Galiatsatos, Jodi Rennert, Nathan A Irvin
Bienvenue sur EM-consulte, la référence des professionnels de santé.